glp-1 ras drugs Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 Receptor Agonists May Improve
Description
Study Design and Population Characteristics This retrospective, real-world study extracted data from electronic medical records of an urban pediatric hospital
Until the data of the SURPASS-CVOT trial are available, tirzepatide will most likely have a place in the algorithm of T2D therapy for patients with obesity and T2D that have the therapeutic aim to normalize glycemia and decrease body weight
Lv YQ, Yuan L, Sun Y, Dou HW, Su JH, Hou ZP, et al
L., & Trujillo, J
Additionally, optimizing access and equity in pharmacotherapy, as well as integrating these treatments into comprehensive care models, are critical areas for future investigation
